{
    "Trade/Device Name(s)": [
        "Roche Acetaminophen Assay"
    ],
    "Submitter Information": "Roche Diagnostics",
    "510(k) Number": "K110726",
    "Predicate Device Reference 510(k) Number(s)": [
        "K991598",
        "K013757",
        "K060373"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "LDP"
    ],
    "Summary Letter Date": "December 7, 2011",
    "Summary Letter Received Date": "December 8, 2011",
    "Submission Date": "",
    "Regulation Number(s)": [
        "21CFR862.3030"
    ],
    "Regulation Name(s)": [
        "Acetaminophen Test System"
    ],
    "Analyte Class(es)": [
        "chemistry",
        "toxicology"
    ],
    "Analyte(s)": [
        "Acetaminophen"
    ],
    "Specimen Type(s)": [
        "Serum",
        "Plasma"
    ],
    "Specimen Container(s)": [
        ""
    ],
    "Instrument(s)/Platform(s)": [
        "Roche COBAS Integra",
        "Roche Hitachi",
        "cobas c system analyzers"
    ],
    "Method(s)/Technology(ies)": [
        "Enzymatic end-point colorimetric assay"
    ],
    "Methodologies": [
        "Enzymatic assay"
    ],
    "Submission Type(s)": [
        "Assay"
    ],
    "Document Summary": "FDA 510(k) summary for Roche Acetaminophen assay for quantitative determination of toxic acetaminophen levels in serum and plasma on Roche automated chemistry analyzers",
    "Indications for Use Summary": "In vitro test for the quantitative determination of toxic levels of acetaminophen in serum and plasma on Roche COBAS Integra, Roche Hitachi and cobas c system analyzers",
    "fda_folder": "Toxicology"
}